Hospitaschen ApS
APSActiveAdvertising protectionCVR 39703424Skovtoftevænget 13, 2830 VirumWholesale of pharmaceutical and medical goods· NACE 4646Est. 2018 · 8 years old1 employeeshttps://www.hospitaschen.dk
Loading company…
Overview
Hospitaschen ApS is a Danish APS based in Virum, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2018, the company has 1 employee and reported revenue of DKK 860.3k in its latest annual filing.
Revenue 2025
860.3K DKK
+174% vs 2024
EBITDA margin
3.7 %
+656% vs 2024
Net profit 2025
29.1K DKK
+240% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
26.9 %
WeakAmong the 40% lowest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
1.4×
AverageAround the average of companies in the same industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
21.5 %
Very strongAmong the 20% highest rated companies in the industry
20212025
EBITDA — year on year
DKK thousandsKey figures
Annual report 2025| Revenue | 860.3K DKK | +174% |
| EBITDA | 31.5K DKK | +656% |
| Net profit | 29.1K DKK | +240% |
| Total assets | 134.9K DKK | -21% |
| Equity | 36.3K DKK | +399% |
| Employees | 1 | — |
Company information
Legal name
Hospitaschen ApS
CVR number
39703424
Legal form
Anpartsselskab
NACE code
Founded
5 July 2018 · 8 years
Share capital
DKK 40,000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør.
Company purpose
Virksomhedens formål er handel med poser til hospitaler.
(no translation available)
Contact
Address
Skovtoftevænget 13, 2830 Virum
Phone
+45 4050 5095
Email
mikael@hospitaschen.dk
Website
https://www.hospitaschen.dk
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Hospitaschen ApS reported revenue of DKK 860.3k, an increase of 174% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 29.1k, and the EBITDA margin stood at 3.7%.
At the end of 2025, equity financed 26.9% of the balance sheet, and current assets covered short-term debt 1.4 times.
Financials
Revenue
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 860 | 314 | 138 | 96 | 327 |
| Staff expenses | -184 | -310 | -332 | -0 | -0 |
| EBITDA | 31 | 4 | -194 | 96 | 97 |
| Depreciation & amort. | -0 | -3 | -3 | -3 | -3 |
| EBIT | 31 | 1 | -197 | 93 | 94 |
| Net financials | -2 | -20 | -5 | -3 | 0 |
| Profit before tax | 29 | -19 | -201 | 89 | 94 |
| Tax | -0 | 2 | -0 | 18 | 22 |
| Net profit | 29 | -21 | -201 | 71 | 72 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 135 | 171 | 201 | 495 | 653 |
| Equity | 36 | 7 | 28 | 229 | 160 |
| Long-term debt | 5 | 0 | 0 | 176 | 0 |
| Short-term debt | 94 | 164 | 173 | 91 | 491 |
| Total debt | 99 | 164 | 173 | 266 | 491 |
Financial ratios
5-year trendEBITDA margin
3.7 %
20212025
Equity ratio
26.9 %
WeakAmong the 40% lowest rated companies in the industry
20212025
Return on equity
80.0 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Net profit margin
3.4 %
StrongAmong the 40% highest rated companies in the industry
20212025
Asset turnover
6.38×
Very strongAmong the 10% highest rated companies in the industry
20212025
Debt / equity
2.71×
WeakAmong the 30% lowest rated companies in the industry
20212025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginStrong
Among the 40% highest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginStrong
Among the 40% highest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginStrong
Among the 40% highest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Very strong
Among the 10% highest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very strong
Among the 20% highest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very strong
Among the 10% highest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very strong
Among the 20% highest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioAverage
Around the average of companies in the same industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioAverage
Around the average of companies in the same industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioAverage
Around the average of companies in the same industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 10% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery weak
Among the 20% lowest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioWeak
Among the 40% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioWeak
Among the 40% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityWeak
Among the 30% lowest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityWeak
Among the 30% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtStrong
Among the 30% highest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtStrong
Among the 30% highest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageStrong
Among the 30% highest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtAverage
Around the average of companies in the same industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery strong
Among the 20% highest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverVery strong
Among the 10% highest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverWeak
Among the 40% lowest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalWeak
Among the 30% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery strong
Among the 10% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery strong
Among the 20% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KJ Founder | Founder | 2018 |
MM Management | Management | 2021 |
Board of directors
Non-executive oversightNo data on file.
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Individual | 50–66.65% | 50–66.65% | 2018 | |
| Individual | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
JYSK FRIGG ApS
Hospitaschen ApS Board network connections
Board members of Hospitaschen ApS also hold positions in 1 other company.
| Person | Role here | Other companies |
|---|---|---|
| Karsten Jørgensen | Founder | 1 company |
Frequently asked questions
What is the CVR number of Hospitaschen ApS?
Hospitaschen ApS is registered with CVR / Virk under CVR 39703424.
What is the revenue of Hospitaschen ApS?
Hospitaschen ApS reported revenue of DKK 860.3k in 2025.
How many employees does Hospitaschen ApS have?
Hospitaschen ApS employs 1 people as of the latest annual report.
Where is Hospitaschen ApS headquartered?
Hospitaschen ApS's registered address is Skovtoftevænget 13.